Urometer Market (2026 - 2033)

Urometer Market Summary

The global urometer market size was valued at USD 606.2 million in 2025 and is projected to grow from USD 649.2 million in 2026 to USD 1,046.3 million in 2033, at a CAGR of 7.1% from 2026 to 2033. Asia Pacific dominated the market, accounting for a revenue share of 30.0% in 2025. This is attributable to the rising prevalence of urological illnesses, which includes kidney stones, urinary retention, cystitis, benign prostatic hyperplasia, urine incontinence, and bladder dysfunction. 

Key Market Trends & Insights

• By product: The 500 ml segment dominated the market, accounting for 35.0% in 2025.
• By application: The operative procedures accounted for the largest market revenue share in 2025.
• By end-use: The hospitals segment dominated the market in 2025.

Regional Insights

• Largest regional market: Asia Pacific (30.0% revenue share, 2025)
• By country: China held the largest market share in 2025.

Market Size & Forecast

• Market size in 2025: USD 606.2 Million
• Estimated market size in 2026: USD 649.2 Million
• Projected market size by 2033: USD 1,046.3 Million
• CAGR (2026-2033): 7.1%

The need for home healthcare facilities, a steady growth in geriatrics population, and the growing healthcare expenditure and improving access to healthcare services are all contributing to the market expansion. The aging population is another significant factor driving the growth of the urometer market. According to the World Health Organization (WHO), urinary incontinence is a highly prevalent condition among older adults, particularly those aged 60 years and above, with urge and stress urinary incontinence being among the most common forms in this population. Recent demographic trends further highlight this growth opportunity. According to the United Nations World Population Prospects 2024, the share of the global population aged 65 and above is projected to increase from approximately 10.4% in 2025 to 16.7% by 2050. This rapid aging trend is expected to increase the prevalence of urine management issues, including incontinence, leakage, chronic kidney disease (CKD), and urinary retention, thereby supporting demand for urine output monitoring and urinary drainage devices such as urometers across hospitals, long-term care facilities, and home healthcare settings.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

In addition, the increasing prevalence of chronic diseases such as diabetes, hypertension, cardiovascular disorders, and chronic kidney disease (CKD) is driving the demand for continuous urine output monitoring across healthcare settings. Patients admitted to intensive care units (ICUs), undergoing major surgical procedures, or receiving treatment for acute kidney injury (AKI) require accurate monitoring of urinary output to assess renal function, fluid balance, and treatment response. Furthermore, the growing number of surgical procedures, expansion of critical care infrastructure, increasing healthcare expenditure, and continuous product innovations by leading manufacturers are expected to support the adoption of urometers over the forecast period.

Moreover, the growing emphasis on infection prevention and patient safety is encouraging healthcare providers to adopt disposable, closed-system urometers to reduce the risk of catheter-associated urinary tract infections (CAUTIs). The increasing shift toward home healthcare services, supported by advancements in portable urinary monitoring solutions and remote patient care, is also expected to create new growth opportunities for market participants in the coming years.

Analyst Perspective

The urometer market is set for steady growth, driven by rising demand for accurate urine output monitoring across ICUs, emergency departments, and home healthcare. Key demand drivers include an expanding geriatric population and the increasing prevalence of urological disorders, chronic kidney disease, and surgical procedures requiring reliable fluid balance tracking. Technological advancements—such as disposable, closed-system urometers—are enhancing patient safety and reducing catheter-associated urinary tract infections (CAUTIs). Growth is further supported by expanding critical care infrastructure, rising healthcare spending, and continuous product innovation. Despite pricing pressures and alternative monitoring solutions, the market outlook remains strong as healthcare providers prioritize infection prevention and precise patient care.

Product Insights

The 500 mL segment dominated the urometer market, accounting for 35.0% of the revenue share in 2025, and is also expected to register the fastest CAGR over the forecast period. The segment's growth is driven by the widespread use of 500 mL urometers in hospitals and intensive care units (ICUs) to accurate measurement of short-term urine output in postoperative and critically ill patients. Increasing prevalence of urological disorders, including urinary incontinence, bladder cancer, benign prostatic hyperplasia (BPH), and chronic kidney disease (CKD), along with the rising number of urological, gynecological, and other major surgical procedures, continues to drive demand for this product category.

Furthermore, the growing geriatric population, which is at a higher risk of urinary and renal disorders, is expected to support market growth over the forecast period. Rising hospital admissions, increasing utilization of critical care services, and the need for continuous monitoring of fluid balance and renal function are further contributing to the adoption of 500 mL urometers across healthcare settings.

Application Insights

The operative procedures segment accounted for the largest revenue share of the urometer market in 2025. The segment is driven by the increasing volume of surgical procedures requiring continuous postoperative urine output monitoring to assess kidney function, fluid balance, and patient recovery. The growing prevalence of urological, cardiovascular, gastrointestinal, gynecological, and other major surgeries, coupled with expanding hospital infrastructure and increasing adoption of minimally invasive surgical techniques, is expected to support demand for urometers. For instance, in April 2025, Medtronic announced that the Expand URO U.S. clinical trial met safety and effectiveness endpoints for the Hugo robotic-assisted surgery system, highlighting the growing adoption of advanced urologic procedures that often require post-operative urine output monitoring. The emergency trauma segment is expected to register the fastest CAGR over the forecast period. Growth is driven by the increasing incidence of road traffic accidents, traumatic injuries, and emergency admissions requiring rapid assessment of urine output as a key indicator of renal perfusion and fluid status. In addition, the expansion of emergency departments, trauma centers, and intensive care units (ICUs), along with improvements in emergency medical services and critical care infrastructure, is expected to further accelerate the adoption of urometers in trauma and emergency settings.

End-use Insights

The hospitals segment dominated the urometer market in 2025, owing to the high volume of inpatient admissions, surgical procedures, and critical care cases requiring continuous urine output monitoring. Hospitals are the primary end users of urometers due to the rising prevalence of urological disorders, chronic kidney disease (CKD), urinary retention, and other conditions requiring accurate monitoring of urinary output. In addition, the widespread availability of intensive care units (ICUs), emergency departments, and advanced postoperative care facilities continues to support segment growth.

The home healthcare segment is expected to register the fastest CAGR over the forecast period. Growth is driven by the increasing preference for home-based care among the aging population and patients with chronic urological conditions, rising healthcare costs, and the growing adoption of portable and user-friendly urinary drainage and monitoring devices. Furthermore, advancements in remote patient monitoring, expansion of home healthcare services, and the increasing availability of non-invasive urinary care solutions are expected to further accelerate demand in this segment.

Regional Insights

North America is expected to witness moderate growth over the forecast period. The regional market is driven by the rising prevalence of urological disorders, including benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary retention, bladder cancer, and chronic kidney disease. In addition, the growing geriatric population, increasing number of urological and postoperative procedures, well-established healthcare infrastructure, and high adoption of advanced urinary drainage, urine collection, and monitoring devices are supporting market growth. Furthermore, favorable reimbursement policies and the strong presence of leading medical device manufacturers continue to drive product adoption across hospitals and long-term care facilities. For instance, in November 2025, BD expanded its PureWick portfolio with a first-of-its-kind portable solution designed to help manage urinary incontinence, reflecting the growing demand for urinary care products in North America.

Asia Pacific Urometer Market Trends

Asia Pacific dominated the global urometer market in 2025, accounting for 30.0% of the global revenue, and is expected to register the fastest CAGR during the forecast period. The regional market is driven by its large and aging population, the increasing prevalence of urological disorders, the rising number of surgical procedures, and the expanding healthcare infrastructure in emerging economies such as China and India. In addition, growing healthcare expenditure, increasing hospital admissions, and improving access to critical care services and postoperative patient monitoring are accelerating the adoption of urometers in the region.

To learn more about this report, Download Free Sample Report

China accounted for a substantial share of the Asia-Pacific urometer market in 2025, supported by its rapidly expanding geriatric population and the rising incidence of urinary incontinence, benign prostatic hyperplasia (BPH), chronic kidney disease, and other urological disorders. Furthermore, continued investments in healthcare infrastructure, rising surgical volumes, and the expansion of hospital and intensive care facilities are driving demand for urine output monitoring devices such as urometers.

Key Urometer Market Company Insights

The market is highly fragmented due to numerous global, regional, and local manufacturers. Competition is driven by product quality, innovation, distribution networks, and pricing strategies. Companies are increasingly focusing on expanding their urinary drainage product portfolios, improving patient safety, and strengthening their presence through product launches and strategic partnerships.

• BD (Becton, Dickinson and Company) designs, manufactures, and markets a broad portfolio of medical devices, including urinary drainage systems, urometers, catheters, and infection prevention solutions. The company serves hospitals, clinics, and other healthcare facilities worldwide.
• Teleflex Incorporated designs and manufactures medical devices for critical care, urology, and surgery. Its product portfolio includes urinary catheters, urine collection systems, urometers, airway management devices, vascular access products, and anesthesia equipment.

Key Urometer Companies

The following key companies have been profiled for this study on the urometer market.

• BD

• Teleflex Incorporated.

• Cardinal Health.

• Medline.

• Convatec Inc.

• Forlong Medical Co.,Ltd

• Hitec Medical

• Laborie.

• Fannin

• Observe Medical ASA

Recent Developments

• In May 2026, Unoquip introduced the Q500 Plus Diuresis Measuring System, a next-generation urine output monitoring solution designed to improve the accuracy and reliability of diuresis measurement in clinical settings. This development highlights ongoing innovation in urinary monitoring technologies and supports the growing demand for advanced urometer solutions in hospitals and post-operative care environments.

• In January 2024, Cardinal Health acquired Specialty for USD 1.2 billion. The acquisition was expected to enable Cardinal Health to expand its reach in specialty medicines and improve data analysis, providing doctors with better insights for patient care. The acquisition strengthened Cardinal Health's specialty pharmaceutical capabilities and enhanced its data-driven patient care solutions.

Global Urometer Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global urometer market report based on product, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • 100 ml

  • 200 ml

  • 400 ml

  • 450 ml

  • 500 ml

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Operative Procedures

  • Emergency Trauma

  • Palliative Care

  • Others

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospital

  • Clinics

  • Home Healthcare

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait